Description: Retatrutide is an investigational multi‑agonist peptide that activates GLP‑1, GIP, and glucagon receptors to reduce body weight and improve metabolic parameters in preclinical and clinical research. Supplied for pharmacology and metabolic research into appetite, energy balance, and glucose homeostasis.
Intended use: RESEARCH CHEMICAL — for in vitro testing and laboratory or regulated clinical research by qualified professionals only. Not for administration to humans or animals outside approved studies. Not a drug, food, or cosmetic; do not misbrand, misuse, or mislabel.